Scientific directorS

Inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC) are chronic diseases that significantly impact on patients’ lives. Novel diagnostic and interventional techniques, imaging modalities and the introduction of biologics and small molecule have dramatically improved their management and outcomes.

The main aim of this congress is to focus the attention of practicing IBD experts on the most novel imaging modalities, the use of new drugs, and how to integrate them in daily clinical practice.
Several interactive clinical cases will be presented and discussed to deliver the learning objectives.

•⁠ ⁠Interventional endoscopy in CD management
•⁠ ⁠Abscess and fistula management outside of perianal region in CD
•⁠ ⁠Difficult cases in UC

•⁠ ⁠Small bowel imaging and management
•⁠ ⁠Pouchitis management
•⁠ ⁠Clinical challenges in TDM daily practice

This educational activity is independent and it is sponsored by
Abbvie, Abivax, Celltrion, Eli Lilly, Jansse, Sandoz, Takeda